Bellevue Life Sciences-RTSBLACRPreferred / convertible
13F holders, Q2 2024 (June 30)At the end of Q2 2024, 30 institutions reported holding Bellevue Life Sciences-RTS (BLACR) in their 13F filings, down 1 from Q1 2024. 2 opened new positions and 3 sold out. The largest holders were Highbridge Capital Management LLC ($93K), Periscope Capital Inc. ($59K) and Polar Asset Management Partners Inc. ($43K). 2 famous investors held it, including David E. Shaw ( of D. E. Shaw & Co.'s portfolio) and Ken Griffin ( of Citadel Advisors's portfolio).
- Company
- Bellevue Life Sciences-RTS
- CUSIP
- 079174124
- Latest filing quarter
- Q4 2024
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $28K |
| Exits | 3 | $28K |
All 13F filers, Q1 2024 → Q2 2024: 350,976 shares bought and 645,526 shares sold, net −294,550 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 30 holders
| Highbridge Capital Management LLC | — | No change | 836,469 | $93K |
| Periscope Capital Inc. | — | Reduce -46.1% | 488,600 | $59K |
| Polar Asset Management Partners Inc. | — | No change | 360,000 | $43K |
| Boothbay Fund Management, LLC | — | No change | 311,040 | $37K |
| JPMorgan Chase & Co. | — | No change | 300,000 | $33K |
| Atw Spac Management LLC | — | No change | 311,040 | $31K |
| Saba Capital Management, L.P. | — | No change | 250,000 | $30K |
| Shaolin Capital Management LLC | — | Add +38.9% | 263,867 | $26K |
| Rivernorth Capital Management, LLC | — | No change | 250,000 | $25K |
| Cowen and Company, LLC | — | New | 249,855 | $25K |
| Clear Street LLC | — | No change | 190,858 | $19K |
| Exos Asset Management LLC | — | Reduce -10.6% | 178,900 | $18K |
| Walleye Capital LLC | — | No change | 168,128 | $17K |
| D. E. Shaw & Co. | — | No change | 150,000 | $17K |
| CVI Holdings, LLC | — | No change | 156,176 | $16K |
| Wolverine Asset Management LLC | — | No change | 121,585 | $12K |
| AQR Arbitrage LLC | — | No change | 100,000 | $11K |
| Centiva Capital, LP | — | No change | 100,000 | $11K |
| Walleye Trading LLC | — | No change | 94,572 | $9K |
| Mint Tower Capital Management B.V. | — | No change | 75,000 | $8K |
| Schechter Investment Advisors, LLC | — | Reduce -2.1% | 45,500 | $5K |
| SkyView Investment Advisors, LLC | — | No change | 30,000 | $4K |
| Citadel Advisors | — | New | 24,583 | $3K |
| Gabelli Funds LLC | — | No change | 27,050 | $3K |
| GABELLI & Co INVESTMENT ADVISERS, INC. | — | No change | 20,800 | $2K |
| Bulldog Investors, LLP | — | No change | 19,640 | $2K |
| Wealthspring Capital LLC | — | Reduce -21.6% | 12,900 | $1K |
| Flow Traders U.S. LLC | — | Add +22.5% | 14,521 | $1K |
| Bank of America Corp. | — | No change | 100 | $10 |
| UBS Group AG | — | No change | 22 | $2 |
"% of holder's portfolio" is BLACR's weight in each manager's 13F, not the share of Bellevue Life Sciences-RTS the manager owns.